Queen’s Award for Enterprise In International Trade 2009 For Evaluate Ltd

LONDON - Evaluate Ltd, the parent company of EvaluatePharma(R), the premier online analysis service for the global pharmaceutical industry, is announced today as a winner of the coveted Queen’s Award for Enterprise in International Trade.

The Queen’s Awards for Enterprise are the UK’s most prestigious Awards for business performance. They recognise and reward outstanding achievement by UK companies. In receiving the Award, London based Evaluate Ltd has been recognised for demonstrating outstanding growth in overseas earnings for a company of its size. In the last three years sales of the EvaluatePharma(R) service have more than doubled outside the UK. As a result, the EvaluatePharma(R) service has grown to serve users located across the globe including New York, New Jersey, Tokyo, Basel, Berlin, Paris and London. This is an impressive pace of growth for a company that began life only twelve years ago working out of a run down business centre in south west London.

At the company’s headquarters in London, CEO and Founder Dr. Jonathan de Pass said, “We are enormously proud to receive our first Queen’s Award for Enterprise and it is an impressive achievement by all our staff both here in the UK and in the US. Our growth has focused on the US, Swiss and German markets and is a reflection of our innovative approach to providing clients with unique, reliable and fast solutions to their analytical needs.”

Dr. de Pass, a former top-ranked Pharmaceutical analyst in the City of London, set up Evaluate Ltd in 1996 to provide reliable and comprehensive pharma business data to investment analysts and industry insiders, “Our rapid growth in the last few years has allowed us to invest in our people, and our proprietary software platform, to deliver the highest quality service to our clients. We now have over 35 UK based employees with a dedicated team of in-house analysts and software programmers, plus sales and client support teams based in the UK and US. The Queen’s Award for Enterprise is high and public recognition so winning this Award is an honour for everyone involved.”

Evaluate Ltd’s loyal and growing client base includes the top global pharma and biotech companies, the investment banking community and the leading global management consulting firms. The Company intends to launch more innovative developments to the EvaluatePharma(R) service throughout 2009 as it continues to build upon its success and focuses on bringing even greater value to its clients.

Notes to Editors:

Evaluate Ltd is the parent company of EvaluatePharma(R), the premier online analysis service for the global pharmaceutical and biotechnology sector.

Set up in 1996 by Dr. Jonathan de Pass, EvaluatePharma(R) provides proprietary insight into the commercial and financial prospects of the pharma and biotech industry and was the first company to provide reliable consensus forecasts of global drug sales. EvaluatePharma’s powerful proprietary software platform offers a user friendly web interface that makes complex analysis simple, providing analysis and insights not available anywhere else. In 2007 EvaluatePharma(R)Alpha was launched offering a valuation service designed to quantify market events and the impact on product, portfolio and company valuation.

EvaluatePharma(R), EvaluatePharma(R)Alpha, and EP Vantage are services of EvaluatePharma Ltd, headquartered in London, England. In North America, EvaluatePharma Ltd is represented by EvaluatePharma USA, Inc (Wilmington, Delaware).

Contact: Joanna Southward +44(0)20-7539-5413 joannas@evaluatepharma.com Andrew Beaven +44(0)20-7539-1818 andrewb@evaluatepharma.com

Source: Evaluate Pharma

Contact: Joanna Southward, +44(0)20-7539-5413, joannas at evaluatepharma.com; Andrew Beaven, +44(0)20-7539-1818, andrewb at evaluatepharma.com